deltatrials
Completed NCT00458562

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

HIV-Associated DNA Hypermethylation in Cervical Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Cervical Cancer Precancerous Condition
Updated 10 times since 2017 Last updated: Nov 15, 2013 Started: Jan 31, 2006 Primary completion: Nov 30, 2012 Completion: Nov 30, 2012

This observational or N/A phase trial investigates Cervical Cancer and Precancerous Condition and is currently completed. National Cancer Institute (NCI) leads this study, which shows 10 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 5 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Completed

  2. May 2018 — Jun 2018 [monthly]

    Completed

  3. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  4. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  5. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • University of Washington
Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Dakar, Senegal